Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Carlos Rondon-Clavo
Early Fluid Overload Is a Serious Toxicity Associated With an Increased Risk of Non-Relapse Mortality After Ex-Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Co-Infections by Double-Stranded DNA Viruses After Ex Vivo T Cell–Depleted, CD34 + Selected Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
CD34-selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed, High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Enlarged Spleen Prior to Allogeneic Transplantation for Myelofibrosis Is Associated With Poor Engraftment and Increased Non-Relapse Mortality
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
CD34+ Selected Ex-Vivo T-Cell Depleted (TCD) Grafts for Allogeneic Hematopoietic Cell Transplantation (Allo-Hsct) Is Associated With Low Incidence of Acute and Chronic Graft-Versus-Host Disease (GVHD) and High Chronic-GVHD/Relapse-Free Survival
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Azithromycin Exposure Following Hematopoietic Stem Cell Transplantation Is Associated With an Increased Risk of Cancer Relapse in Acute Leukemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Long-Term Prognosis for 1-Year Relapse-Free Survivors of CD34+ Cell-Selected Allogeneic Hematopoietic Stem Cell Transplantation: A Landmark Analysis
Bone Marrow Transplantation
Transplantation
Hematology
Pre-Transplant Diabetes Mellitus Is a Risk Factor for Non-Relapse Mortality, Especially Infection-Related Mortality, After Allogeneic Hematopoietic SCT
Bone Marrow Transplantation
Transplantation
Hematology
Cytomegalovirus Reactivation Is Associated With Increased Mortality More Than 100 Days After Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma
American Journal of Hematology
Hematology
Peri-Transplant RBC Transfusion Is Associated With Increased Risk of GvHD After Allogeneic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
